Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
-
Published:2024-05
Issue:
Volume:218
Page:63-67
-
ISSN:0002-9149
-
Container-title:The American Journal of Cardiology
-
language:en
-
Short-container-title:The American Journal of Cardiology
Author:
Alturkmani HaniORCID,
Uretsky Barry,
Patel Swetal,
Albadaineh Mu'nes,
Alqaisi Omar,
Alaiwah Malek,
Cross Michael,
Abbasi Danish,
Rollefson William
Reference23 articles.
1. Heparin and low-molecular-weight heparin;Gray;Thromb Haemost,2008
2. The anticoagulant and antithrombotic mechanisms of heparin;Gray;Handb Exp Pharmacol,2012
3. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety;Hirsh;Chest,2001
4. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Lawton;J Am Coll Cardiol,2022
5. Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis;Borentain;Catheter Cardiovasc Interv,2005